Drawing for SIFTAXYS

USPTO serial 79423293

SIFTAXYS

Reviewed by CopyMark Law Group

Reg. 8112974Status 700Registered
Filing date
Status date
Registration date
Jan 27, 2026
Examiner
GLUECK, CHRISTOPHER N
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SIFTAXYS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pina M. Campagna

Pina M. Campagna Carter, DeLuca, & Farrell, LLP576 Broad Hollow RoadMelville, NY 11747United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical products and preparations used for the treatment of cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; pharmaceuticals used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseasesACTIVE—
010Medical and surgical apparatus and instruments for use in gastrointestinal surgery; drug delivery devices in the nature of medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations, namely, a kit comprising a suspension bag and administration tube set, sold empty; Drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, namely, syringes, infusion sets, implantable devices sold empty; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set sold without medicationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 7, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 7, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 27, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 6, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 6, 2026FIMPFINAL DISPOSITION PROCESSED—
Apr 27, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 27, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 27, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 11, 2025GPNXNOTIFICATION PROCESSED BY IB—
Dec 9, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 9, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 26, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 25, 2025OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 13, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 12, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 12, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Nov 12, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 12, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 12, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 29, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 29, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 29, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2025RFNTREFUSAL PROCESSED BY IB—
Aug 8, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 7, 2025RFRRREFUSAL PROCESSED BY MPU—
Jun 21, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 20, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2025DOCKASSIGNED TO EXAMINER—
May 12, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
May 12, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance